K2M Expands MESA Platform with FDA Clearance for Sagittal Imbalance Application

K2M received an additional FDA 510(k) clearance for the MESA® Spinal System, providing for use of the Dual Differential Correction (DDC™) Technique to treat sagittal imbalance in idiopathic scoliosis patients.

According to K2M, DDC combines rod rigidity and degree of bend with the MESA platform to achieve sagittal plane correction.

As part...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us